BPC-157 (10mg)

BPC-157 10mg, a pentadecapeptide for growth factor research. (99%) Purity verified here on Australian soil at The University of Melbourne.

BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide originally isolated from human gastric juice protein. First characterised in the 1990s, it has become one of the most extensively studied peptides in tissue repair literature, with over 100 published preclinical studies examining its mechanisms and potential applications.

The peptide sequence (GEPPPGKPADDAGLV) is derived from a larger protective protein found naturally in gastric juice. Unlike many peptides, BPC-157 demonstrates stability in gastric acid conditions, which has made it particularly interesting for research applications.

Research has examined BPC-157’s effects on angiogenesis through the VEGFR2 pathway, nitric oxide system modulation, and growth factor expression across various tissue models including tendon, muscle, ligament, and gastrointestinal tissue. Studies have also investigated its interaction with the dopaminergic system, GABAergic pathways, and the nitric oxide system.

Additional research has explored BPC-157’s effects on fibroblast migration, collagen formation, and blood vessel growth in tissue models. The peptide has been studied alongside growth factors including EGF, FGF2, and VEGF to understand potential interactions and mechanisms.

Gen Ex Peptides supplies BPC-157 tested at an Australian university laboratory not generic overseas certificates. Each batch is verified for purity (99%) using HPLC and mass spectrometry.